Pyoderma gangrenosum after radical prostatectomy: case report

[1]  L. French,et al.  Drug-Induced Pyoderma Gangrenosum: A Review , 2018, American Journal of Clinical Dermatology.

[2]  S. Cha,et al.  Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases. , 2016, Mayo Clinic proceedings.

[3]  M. Camilleri,et al.  Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. , 2015, Journal of the American Academy of Dermatology.

[4]  K. Zuo,et al.  A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy. , 2015, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[5]  M. Ye,et al.  Pyoderma Gangrenosum: A Review of Clinical Features and Outcomes of 23 Cases Requiring Inpatient Management , 2014, Dermatology research and practice.

[6]  S. Langan,et al.  Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. , 2012, The Journal of investigative dermatology.

[7]  A. Qureshi,et al.  Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients , 2011, The British journal of dermatology.

[8]  S. Prawer,et al.  Pyoderma gangrenosum of the breasts precipitated by breast surgery. , 2006, Journal of the American Academy of Dermatology.

[9]  R. Weenig,et al.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria , 2004, International journal of dermatology.

[10]  J. Callen,et al.  Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. , 2000, Journal of the American Academy of Dermatology.

[11]  C. Berking,et al.  Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts , 2000, Laboratory Investigation.

[12]  H. Petty,et al.  Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. , 1998, The Journal of investigative dermatology.

[13]  M. Walsh,et al.  Pyoderma gangrenosum of the breast treated with low‐dose cyclosporin A , 1997, Clinical and experimental dermatology.

[14]  W. Su,et al.  Pyoderma gangrenosum: classification and management. , 1996, Journal of the American Academy of Dermatology.

[15]  J I Gallin,et al.  Current concepts: immunology. Neutrophils in human diseases. , 1987, The New England journal of medicine.

[16]  L. Brunsting,et al.  PYODERMA (ECHTHYMA) GANGRENOSUM: CLINICAL AND EXPERIMENTAL OBSERVATIONS IN FIVE CASES OCCURRING IN ADULTS , 1930 .